Literature DB >> 8646566

Permeability of the blood-brain barrier to soluble cytokine receptors.

W A Banks1, S R Plotkin, A J Kastin.   

Abstract

Soluble receptors for cytokines can be important regulators of cytokine function. By binding to their cytokine ligands, they act as antagonists and carrier proteins. We investigated whether the blood-to-brain saturable transport of human tumor necrosis factor-alpha (TNF) and human interleukin-1 alpha (IL-1) radioactively labeled with 125I could be blocked by preincubation with their soluble receptors. At ratios of 100:1 and 1,000:1 of receptor to cytokine, the soluble p75 human receptor to TNF (rhuTNFR:Fc) totally blocked the entry of human or murine TNF into the brain. However, the soluble murine receptor to IL-1 (muIL-1R) only partially blocked IL-1 entry. Radioactively labeled rhuTNFR:Fc and muIL-1R were not transported across the blood-brain barrier (BBB) and were no more able to penetrate the BBB than the vascular marker serum albumin. This indicates that the transporter at the BBB for IL-1, but not the one for TNF, can strip the cytokine from its soluble receptor. These findings might be useful in determining which, if any, of the actions exerted on the brain by blood-borne cytokines are due to penetration of the BBB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8646566     DOI: 10.1159/000096887

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  23 in total

Review 1.  A systematic review of the association between immunogenomic markers and cancer-related fatigue.

Authors:  L N Saligan; H S Kim
Journal:  Brain Behav Immun       Date:  2012-05-14       Impact factor: 7.217

2.  Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma.

Authors:  Gao Guo; Ke Gong; Vineshkumar Thidil Puliyappadamba; Nishah Panchani; Edward Pan; Bipasha Mukherjee; Ziba Damanwalla; Sabrina Bharia; Kimmo J Hatanpaa; David E Gerber; Bruce E Mickey; Toral R Patel; Jann N Sarkaria; Dawen Zhao; Sandeep Burma; Amyn A Habib
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

3.  An animal model for chorioamnionitis at term.

Authors:  Valeria Dell'Ovo; Jason Rosenzweig; Irina Burd; Nana Merabova; Nune Darbinian; Laura Goetzl
Journal:  Am J Obstet Gynecol       Date:  2015-05-12       Impact factor: 8.661

Review 4.  The role of the gut-brain axis in alcohol use disorders.

Authors:  Jonathan Gorky; James Schwaber
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-07-16       Impact factor: 5.067

5.  Differential gene expression during meningeal-meningococcal interaction: evidence for self-defense and early release of cytokines and chemokines.

Authors:  D B Wells; P J Tighe; K G Wooldridge; K Robinson; D A Ala' Aldeen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  How predictive of dementia are peripheral inflammatory markers in the elderly?

Authors:  Andrea L Metti; Jane A Cauley
Journal:  Neurodegener Dis Manag       Date:  2012-12-01

7.  TNFα causes thrombin-dependent vagal neuron apoptosis in inflammatory bowel disease.

Authors:  Danielle Fritze; Weizhen Zhang; Ji-Yao Li; Biaoxin Chai; Michael W Mulholland
Journal:  J Gastrointest Surg       Date:  2014-06-25       Impact factor: 3.452

8.  Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.

Authors:  Edward Tobinick; Nancy M Kim; Gary Reyzin; Helen Rodriguez-Romanacce; Venita DePuy
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

Review 9.  Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

10.  Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging.

Authors:  Edward L Tobinick; Kai Chen; Xiaoyuan Chen
Journal:  BMC Res Notes       Date:  2009-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.